Cargando…

Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults

BACKGROUND: Sexual minority, or lesbian, gay, and bisexual (LGB), individuals are at increased risk for cardiovascular disease attributable to elevated rates of health risk factors. However, although there is clear evidence that statin use can prevent cardiovscular disease in certain adult populatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yi, Wheldon, Christopher W., Shao, Hui, Pepine, Carl J., Handberg, Eileen M., Shenkman, Elizabeth A., Bian, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955377/ https://www.ncbi.nlm.nih.gov/pubmed/33317368 http://dx.doi.org/10.1161/JAHA.120.018233

Ejemplares similares

Indoor Tanning among Sexual and Gender Minority Adolescents and Adults: Results from the 2020 Pennsylvania LGBT Health Needs Assessment
por: Wheldon, Christopher W., et al.
Publicado: (2023)

Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016
por: Yao, Xiaoxi, et al.
Publicado: (2020)

The Prevalence of Potential Prescribing Omissions for Antiplatelets and Statins in Older Adults With Atherosclerotic Cardiovascular Disease
por: Alshehri, Samah, et al.
Publicado: (2023)

Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
por: Zheutlin, Alexander R., et al.
Publicado: (2022)

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
por: Hammond, Michael M., et al.
Publicado: (2023)

Underuse of statins for secondary prevention of atherosclerotic cardiovascular disease events among ambulatory surgical patients
por: Schonberger, Robert B., et al.
Publicado: (2020)

Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis
por: Boettiger, David C, et al.
Publicado: (2020)

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
por: Boettiger, David C, et al.
Publicado: (2021)

The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis
por: Chidambaram, Vignesh, et al.
Publicado: (2021)

Trans-myocardial omega-3 fatty acid gradient in coronary microvascular dysfunction
por: Keeley, Ellen C., et al.
Publicado: (2022)

Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
por: Wang, Miao, et al.
Publicado: (2020)

Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System
por: Dorsch, Michael P., et al.
Publicado: (2019)

Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study
por: Ryou, In Sun, et al.
Publicado: (2022)

Distinct Gene Expression Profiles in Colonic Organoids from Normotensive and the Spontaneously Hypertensive Rats
por: Li, Jing, et al.
Publicado: (2021)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases
por: Lee, Myunhee, et al.
Publicado: (2023)

Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial
por: Dasa, Osama, et al.
Publicado: (2021)

Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study
por: Yang, Quanhe, et al.
Publicado: (2017)

Ischemia and No Obstructive Coronary Artery Disease (INOCA): What Is the Risk?
por: Herscovici, Romana, et al.
Publicado: (2018)

Statin effects on atherosclerotic plaques: regression or healing?
por: Bittencourt, Marcio Sommer, et al.
Publicado: (2015)

Controlling the thickness of the atherosclerotic plaque by statin medication
por: Formanowicz, Dorota, et al.
Publicado: (2020)

Statins for primary cardiovascular prevention in the elderly
por: Pedro-Botet, Juan, et al.
Publicado: (2015)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
por: Kao, Yu-Cheng, et al.
Publicado: (2021)

A Six-Day, Lifestyle-Based Immersion Program Mitigates Cardiovascular Risk Factors and Induces Shifts in Gut Microbiota, Specifically Lachnospiraceae, Ruminococcaceae, Faecalibacterium prausnitzii: A Pilot Study
por: Ahrens, Angelica P., et al.
Publicado: (2021)

Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study
por: Ambrosy, Andrew P., et al.
Publicado: (2021)

Cardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease Events
por: Weber, Lauren A., et al.
Publicado: (2015)

Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2021)

Antioxidant Effects of Statins in Patients with Atherosclerotic Cerebrovascular Disease
por: Moon, Gyeong Joon, et al.
Publicado: (2014)

Preventable mortality among sexual minority Canadians
por: Salway, Travis, et al.
Publicado: (2022)

Health Disparities of Sexual Minority Patients Following Prostate Cancer Treatment: Results From the Restore-2 Study
por: Rosser, B. R. Simon, et al.
Publicado: (2022)

Underutilization of Statin Therapy for Secondary Prevention of Cardiovascular Disease Among Older Adults
por: Musich, Shirley, et al.
Publicado: (2019)

It is time to mobilize suicide prevention for sexual and gender minorities in Canada
por: Ferlatte, Olivier, et al.
Publicado: (2020)

Fitness attenuates long-term cardiovascular outcomes in women with ischemic heart disease and metabolic syndrome
por: Quesada, Odayme, et al.
Publicado: (2023)

Tipping the Scales for Older Adults: Time to Consider Body Fat Assessment and Management for Optimal Atherosclerotic Cardiovascular Disease and Stroke Prevention?
por: Simpkins, Alexis N., et al.
Publicado: (2021)

Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
por: Li, Yi-Heng, et al.
Publicado: (2020)

Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen
por: Al-Ashwal, Fahmi Y., et al.
Publicado: (2022)

Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A population-based cohort study
por: Lee, Myunhee, et al.
Publicado: (2023)

Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) Study
por: Poudel, Bharat, et al.
Publicado: (2021)

Dialogue: Vitamin D, statins and atherosclerotic progression in paediatric lupus
por: Gilkeson, Gary, et al.
Publicado: (2015)

Simple Integer Risk Score to Determine Prognosis of Patients With Hypertension and Chronic Stable Coronary Artery Disease
por: Bavry, Anthony A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_50ork91oht6vab0ogs0u18heia